Dyne Therapeutics Statistics

Total Valuation

DYN has a market cap or net worth of $1.09 billion. The enterprise value is $433.63 million.

Market Cap	1.09B
Enterprise Value	433.63M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

DYN has 113.67 million shares outstanding. The number of shares has increased by 53.90% in one year.

Current Share Class	113.67M
Shares Outstanding	113.67M
Shares Change (YoY)	+53.90%
Shares Change (QoQ)	+7.78%
Owned by Insiders (%)	0.58%
Owned by Institutions (%)	91.75%
Float	94.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.63
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.35, with a Debt / Equity ratio of 0.03.

Current Ratio	20.35
Quick Ratio	20.00
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.01% and return on invested capital (ROIC) is -41.47%.

Return on Equity (ROE)	-64.01%
Return on Assets (ROA)	-39.92%
Return on Invested Capital (ROIC)	-41.47%
Return on Capital Employed (ROCE)	-57.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.92M
Employee Count	191
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.79% in the last 52 weeks. The beta is 1.16, so DYN's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-71.79%
50-Day Moving Average	11.70
200-Day Moving Average	19.70
Relative Strength Index (RSI)	32.17
Average Volume (20 Days)	2,839,578

Short Selling Information

The latest short interest is 20.62 million, so 18.14% of the outstanding shares have been sold short.

Short Interest	20.62M
Short Previous Month	25.53M
Short % of Shares Out	18.14%
Short % of Float	21.90%
Short Ratio (days to cover)	10.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-397.10M
Pretax Income	-257.40M
Net Income	-367.13M
EBITDA	-395.31M
EBIT	-397.10M
Earnings Per Share (EPS)	-$3.62

Full Income Statement

Balance Sheet

The company has $677.49 million in cash and $23.33 million in debt, giving a net cash position of $654.16 million or $5.76 per share.

Cash & Cash Equivalents	677.49M
Total Debt	23.33M
Net Cash	654.16M
Net Cash Per Share	$5.76
Equity (Book Value)	668.97M
Book Value Per Share	5.89
Working Capital	655.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$319.73 million and capital expenditures -$3.17 million, giving a free cash flow of -$322.89 million.

Operating Cash Flow	-319.73M
Capital Expenditures	-3.17M
Free Cash Flow	-322.89M
FCF Per Share	-$2.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DYN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.90%
Shareholder Yield	-53.90%
Earnings Yield	-33.75%
FCF Yield	-29.68%

Analyst Forecast

The average price target for DYN is $43.60, which is 355.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$43.60
Price Target Difference	355.59%
Analyst Consensus	Strong Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-31.87%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1